interesting to see Ian Ingram, chair, spending $2.25m to buy 1.8m shares. he already holds quite a few most indirectly
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025